两性霉素B对感染白色念珠菌小鼠的免疫佐剂活性。
Immunoadjuvant activity of amphotericin B as displayed in mice infected with Candida albicans.
作者信息
Bistoni F, Vecchiarelli A, Mazzolla R, Puccetti P, Marconi P, Garaci E
出版信息
Antimicrob Agents Chemother. 1985 Apr;27(4):625-31. doi: 10.1128/AAC.27.4.625.
Abstract
Mice receiving a single intraperitoneal injection of amphotericin B showed increased resistance to subsequent challenge with either Candida albicans or Staphylococcus aureus. This enhancement of resistance was obvious in terms of both survival criteria and clearance of the intravenously injected organism from different organs. The protective effect of amphotericin B was conditioned by dose, time of drug administration, and size of yeast or bacterial inoculum and was reversed by cyclophosphamide. Effector cells from mice treated with amphotericin B displayed enhanced fungicidal activity in vitro as measured in a short-term 51Cr release assay. Macrophages from intact animals exposed in vitro to amphotericin B also acquired strong candidacidal reactivity.
摘要
接受单次腹腔注射两性霉素B的小鼠对随后白色念珠菌或金黄色葡萄球菌的攻击显示出抵抗力增强。就生存标准和从不同器官清除静脉注射的生物体而言，这种抵抗力的增强是明显的。两性霉素B的保护作用受剂量、给药时间、酵母或细菌接种物大小的影响，并被环磷酰胺逆转。用两性霉素B处理的小鼠的效应细胞在短期51Cr释放试验中测量显示出体外杀菌活性增强。体外暴露于两性霉素B的完整动物的巨噬细胞也获得了强烈的杀念珠菌反应性。
相似文献
1
Immunoadjuvant activity of amphotericin B as displayed in mice infected with Candida albicans.
Antimicrob Agents Chemother. 1985 Apr;27(4):625-31. doi: 10.1128/AAC.27.4.625.
2
Involvement of host macrophages in the immunoadjuvant activity of amphotericin B in a mouse fungal infection model.
J Antibiot (Tokyo). 1986 Jun;39(6):846-55. doi: 10.7164/antibiotics.39.846.
3
Immunomodulation by Candida albicans: crucial role of organ colonization and chronic infection with an attenuated agerminative strain of C. albicans for establishment of anti-infectious protection.
J Gen Microbiol. 1988 Sep;134(9):2583-92. doi: 10.1099/00221287-134-9-2583.
4
Comparative efficacies of cilofungin (Ly121019) and amphotericin B against disseminated Candida albicans infection in normal and granulocytopenic mice.
Antimicrob Agents Chemother. 1993 Apr;37(4):729-36. doi: 10.1128/AAC.37.4.729.
5
Preliminary evaluation of immunoadjuvant activity of an orally administered glucan extracted from Candida albicans.
Arzneimittelforschung. 1992 Oct;42(10):1246-50.
6
Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans.
Antimicrob Agents Chemother. 1991 Nov;35(11):2275-81. doi: 10.1128/AAC.35.11.2275.
7
Immunopotentiating effect of amphotericin B on resistance to experimental Candida infection in mice.
Ann Ist Super Sanita. 1987;23(4):929-33.
8
Novel aspect of amphotericin B action: accumulation in human monocytes potentiates killing of phagocytosed Candida albicans.
Antimicrob Agents Chemother. 1994 Jan;38(1):13-22. doi: 10.1128/AAC.38.1.13.
9
Aerosolized amphotericin B-liposomes for treatment of systemic Candida infections in mice.
Antimicrob Agents Chemother. 1994 Feb;38(2):356-9. doi: 10.1128/AAC.38.2.356.
10
Role of macrophages in the candidacidal activity of liposomal amphotericin B.
J Infect Dis. 1997 Jan;175(1):214-7. doi: 10.1093/infdis/175.1.214.
引用本文的文献
1
Virulence attenuation of Candida albicans genetic variants isolated from a patient with a recurrent bloodstream infection.
PLoS One. 2010 Apr 13;5(4):e10155. doi: 10.1371/journal.pone.0010155.
2
Immunoenhancement combined with amphotericin B as treatment for experimental visceral leishmaniasis.
Antimicrob Agents Chemother. 2003 Aug;47(8):2513-7. doi: 10.1128/AAC.47.8.2513-2517.2003.
3
Immunization with the Candida albicans membrane fraction and in combination with fluconazole protects against systemic fungal infections.
Antimicrob Agents Chemother. 2000 Feb;44(2):243-7. doi: 10.1128/AAC.44.2.243-247.2000.
4
A new azole derivative of 1,4-benzothiazine increases the antifungal mechanisms of natural effector cells.
Antimicrob Agents Chemother. 1999 Sep;43(9):2170-5. doi: 10.1128/AAC.43.9.2170.
5
Interleukin-12 modulates the protective immune response in SCID mice infected with Histoplasma capsulatum.
Infect Immun. 1997 Mar;65(3):936-42. doi: 10.1128/IAI.65.3.936-942.1997.
6
Novel aspect of amphotericin B action: accumulation in human monocytes potentiates killing of phagocytosed Candida albicans.
Antimicrob Agents Chemother. 1994 Jan;38(1):13-22. doi: 10.1128/AAC.38.1.13.
7
Combined effect of fluconazole and thymosin alpha 1 on systemic candidiasis in mice immunosuppressed by morphine treatments.
Clin Exp Immunol. 1994 Sep;97(3):347-52. doi: 10.1111/j.1365-2249.1994.tb06093.x.
8
Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis.
Antimicrob Agents Chemother. 1985 Dec;28(6):751-5. doi: 10.1128/AAC.28.6.751.
9
Evidence for macrophage-mediated protection against lethal Candida albicans infection.
Infect Immun. 1986 Feb;51(2):668-74. doi: 10.1128/iai.51.2.668-674.1986.
10
Toxicity and induction of resistance to Listeria monocytogenes infection by amphotericin B in inbred strains of mice.
Infect Immun. 1986 Nov;54(2):303-7. doi: 10.1128/iai.54.2.303-307.1986.
本文引用的文献
1
Amphotericin B-induced resistance to Schistosoma mansoni.
J Immunol. 1981 May;126(5):1667-70.
2
A radiolabel release microassay for phagocytic killing of Candida albicans.
J Immunol Methods. 1982 Aug 13;52(3):369-77. doi: 10.1016/0022-1759(82)90008-4.
3
Phagocytic killing of Candida albicans by different murine effector cells.
Sabouraudia. 1983 Dec;21(4):271-86.
4
Natural cell-mediated cytotoxicity against Candida albicans induced by cyclophosphamide: nature of the in vitro cytotoxic effector.
Infect Immun. 1983 Oct;42(1):1-9. doi: 10.1128/iai.42.1.1-9.1983.
5
Correlation between in vivo and in vitro studies of modulation of resistance to experimental Candida albicans infection by cyclophosphamide in mice.
Infect Immun. 1983 Apr;40(1):46-55. doi: 10.1128/iai.40.1.46-55.1983.
6
Immunology of the mycoses. I. Depressed lymphocyte transformation in chronic histoplasmosis.
J Immunol. 1968 Feb;100(2):436-43.
7
Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy.
Clin Exp Immunol. 1971 Nov;9(5):595-602.
8
Changes in murine resistance to Listeria monocytogenes infection induced by amphotericin B.
J Infect Dis. 1973 Apr;127(4):373-7. doi: 10.1093/infdis/127.4.373.
9
Immunological observations in chronic mucocutaneous candidiasis.
Lancet. 1969 Sep 13;2(7620):567-71. doi: 10.1016/s0140-6736(69)90264-5.
10
Response of transplanted AKR leukemia to combination therapy with amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea: dose and schedule dependency.
J Natl Cancer Inst. 1977 Apr;58(4):949-53. doi: 10.1093/jnci/58.4.949.
Zotero 插件